By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



P.O. Box 9595

New Haven  Connecticut  06535  U.S.A.
Phone: 203-687-0753 Fax:



Company News
Rennova Health Achieves Corporate Milestone With Recent Acquisition Of GENOMAS LLC 11/2/2016 10:15:35 AM
Rennova Health Signs Definitive Agreement To Acquire Pharmacogenetic Laboratory, GENOMAS LLC 9/29/2016 10:41:35 AM
GENOMAS LLC Expands Personalized Medicine Business With Clinical Laboratory Licenses in New York, Florida, California 3/4/2013 10:11:54 AM
GENOMAS LLC Awarded $1.4 Million National Institutes of Health (NIH) SBIR Grant to Develop MRI+DNA Guided Biomarker System 9/15/2009 8:36:25 AM
GENOMAS LLC Presents Drug-Specific Genetic Determinants of Statin Safety and Efficacy at the XV International Symposium on Atherosclerosis 6/15/2009 10:53:52 AM
Cardiovascular Side Effects of Pioglitazone and Rosiglitazone Linked to Vascular and Energy Pathways by GENOMAS LLC Clinical Study 1/21/2009 6:57:57 AM
GENOMAS LLC Clinical Study Finds Increased Prevalence of Drug Metabolism Deficiencies in Patients With Serious Psychotropic Side Effects 12/10/2008 7:38:13 AM
GENOMAS LLC Awarded $1.2 Million National Institutes of Health (NIH) SBIR Grant to Develop DNA-Guided System for Management of Statin Therapy 3/20/2008 8:20:07 AM
Genomas Announces Physiogenomic Study That Reveals Potential Cause of Metabolic Side Effects in Patients Treated With Psychotropic Drugs 1/5/2007 12:02:40 PM
GENOMAS LLC And Illumina, Inc. (ILMN) Form Strategic Alliance On Physiogenomics Of Metabolic Syndrome10/19/2005 5:08:58 PM